Growth Stocks To Add to Your Watchlist - September 26th

Key Points

• The article highlights three growth stocks to watch: Teledyne Technologies, Prologis, and Ascendis Pharma A/S, which have shown the highest trading volumes recently.
• Teledyne Technologies focuses on enabling technologies for industrial growth markets, while Prologis leads in logistics real estate, owning or investing in around 1.2 billion square feet globally.
• Ascendis Pharma A/S is a biopharmaceutical company developing therapies for unmet medical needs, including treatments for growth hormone deficiency and rare endocrine diseases.

Teledyne Technologies, Prologis, and Ascendis Pharma A/S are the three Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies expected to grow their revenues and earnings at an above-average rate compared with the overall market. Such companies typically reinvest profits back into the business (for research, development or expansion) rather than paying out dividends. Investors buy growth stocks primarily for the potential of substantial capital appreciation over time. These companies had the highest dollar trading volume of any Growth stocks within the last several days.

Teledyne Technologies (TDY)

Teledyne Technologies Incorporated, together with its subsidiaries, provides enabling technologies for industrial growth markets in the United States and internationally. Its Digital Imaging segment provides visible spectrum sensors and digital cameras; and infrared, ultraviolet, visible, and X-ray spectra; as well as micro electromechanical systems and semiconductors, including analog-to-digital and digital-to-analog converters.

Read Our Latest Research Report on TDY

Prologis (PLD)

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. At March 31, 2024, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 1.2 billion square feet (115 million square meters) in 19 countries.

Read Our Latest Research Report on PLD

Ascendis Pharma A/S (ASND)

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates.

Read Our Latest Research Report on ASND